ASCL1 and lung adenocarcinoma: Importantly, ASCL1 was sufficient to increase NE and CSC markers (Fig. 3b, left panel), which were enhanced with ENZ treatment (Supplementary Fig. 3c), similar results were observed in lung adenocarcinoma (Supplementary Fig. 3d).